The Business
NN, Inc. (NASDAQ: NNBR), based in Charlotte, NC and founded in 1980, engineers and manufactures high-precision metal and plastic components and assemblies. Historically it was a low-margin supplier tied heavily to autos and general industrial markets, carrying too much debt — the kind of sleepy small cap that goes nowhere for years.
The story now is a management-led turnaround (under CEO Harold Bevis) organized around a "5 Pillar" growth program that repositions the mix toward higher-margin, faster-growing end markets:
- Data Center & Electric Grid — precision parts for liquid-cooling systems, transformers, electrical disconnects, and circuit protection. This is now NN's second-largest market at roughly $80M trailing revenue, with a stated near-term goal of $120M+.
- Defense & Electronics — components for weapons and guidance systems, with anti-drone munitions being evaluated.
- Medical — precision parts for medical-equipment and instrument OEMs, including robotic surgery (small today at ~$15M but growing).
The through-line: NN is an indirect, several-layers-down way to play the AI/data-center buildout and grid expansion — it doesn't make chips or servers, it makes the precision hardware that the cooling and power infrastructure around them need — bundled with defense and reshoring exposure.
Where the Price Is
As of the September 29 session (quote pulled live from Yahoo Finance):
- Price: ~$3.88 (+4.3% on the day)
- 52-week range: $1.10–$4.48 — the stock has roughly 3.5x'd off its low and now sits about 13% below its high
- 50-day MA: ~$3.58 — price is ~8% above it
- 200-day MA: ~$2.43 — price is ~59% above it; a strong, established uptrend
- RSI(14): ~60 — firm but not overbought, with room
- Market cap: roughly $200 million — this is a true small/microcap
Unlike most names in this series, NNBR isn't a de-rated leader — it's a beaten-down microcap in a recovery uptrend, above both moving averages and pressing toward 52-week highs. The technical question here isn't "has it bottomed," it's "how much of the turnaround is already in the price."
The Numbers
The recent results show a real operational inflection:
- Q2 2026 (reported Aug 5): net sales $128.7M, up 19.3% YoY, with an earnings surprise of roughly +175% versus estimates
- New business wins: ~$40M in Q2 across Data Center, Medical, and Defense; full-year new-business awards guidance raised to $80–100M per year (up ~29%)
- Data-center ramp: on pace to install ~50 new machines in 2026 against a $50M+ and growing pipeline
- Balance sheet: completed a refinancing of the legacy preferred stock that had been in place over five years — a step toward cleaning up a long-standing capital-structure overhang
- Raised guidance twice: the latest (Sept 22) full-year 2026 outlook is net sales of $470–490M (midpoint ~$480M, +14% YoY) and adjusted EBITDA of $58–68M (midpoint ~$63M, up ~29% YoY)
One honest nuance behind the headline: the +19% total-sales growth is flattered by mix and new programs. The core/continuing business grew more modestly (~5% on the company's adjusted basis) — the acceleration is coming from the new data-center, defense, and medical wins, which are higher-margin but still small in absolute dollars. That's the whole bull-vs-bear tension in one line: a fast-growing new engine bolted onto a slow legacy base.
The Bull Case
- A real, measurable turnaround. Revenue +19%, an earnings beat of ~175%, and guidance raised twice in a quarter — adjusted EBITDA now guided up ~29% year over year. New management is executing, not just promising.
- Mix shift into the right markets. Moving from low-margin legacy auto toward data-center cooling and grid, defense, and medical — higher margin, higher growth, and tied to the strongest secular themes (AI power/cooling, reshoring, defense). Data center is already the #2 market with a path from ~$80M toward $120M+.
- Deleveraging optionality. The preferred-stock refinancing chips away at a capital structure that has long weighed on the equity. For a leveraged small cap, fixing the balance sheet is often where the biggest re-rating comes from.
- Cheap on the growth if it holds. On the raised guide (~$63M adjusted EBITDA), the enterprise trades at a modest mid-single-digit EBITDA multiple — undemanding for ~29% EBITDA growth, reflecting the discount the market puts on microcap turnarounds.
The Bear Case
- It's a sub-$4 leveraged microcap with a poor history. Turnarounds fail often, and NN spent years destroying value under a heavy debt load. The refinancing helps, but leverage and the capital structure remain the central risk — and small-cap turnarounds live or die on the balance sheet.
- The good part is still small. Data center is ~$80M of a ~$480M company; the fast-growing pillars are a minority of revenue, while the larger legacy base grows low-single-digits and stays low-margin and cyclical (autos/industrial).
- Awards aren't revenue yet. Much of the story is new-business awards and pipeline that still have to ramp, get installed (it's capital-intensive — 50 machines), and convert to profitable production. Startup costs and execution risk sit between the announcement and the earnings.
- It already tripled. Up ~3.5x off the lows and near 52-week highs, a lot of the turnaround optimism is priced in. And it's thin and volatile — it was $1.10 within the past year, and momentum microcaps round-trip hard when the story wobbles.
The Thesis
Bull case in a sentence: a credible, management-led turnaround repositioning a forgotten precision-components maker into data-center cooling, grid, defense, and medical — beating and raising, cleaning up its balance sheet, and cheap on the growth if the ramp holds.
Bear case in a sentence: a leveraged sub-$4 microcap whose fast-growing pieces are still a small slice of a slow, cyclical legacy base, trading near highs after a 3.5x run, where the awards-to-earnings conversion and the debt are the whole risk.
What would change my mind, either way: watch (1) the new data-center/defense/medical wins converting into recognized, higher-margin revenue with EBITDA following; (2) continued progress on the balance sheet and leverage; and (3) whether guidance keeps rising into the Q3 report on October 28. Continued beat-and-raise with margin expansion confirms the bull. A ramp delay, a startup-cost margin dent, or any balance-sheet stress confirms the bear.
Trade Plan
Setup: a turnaround microcap in an established uptrend, above both moving averages, pressing toward 52-week highs, with a hard catalyst (Q3 earnings, Oct 28) ahead. This is a momentum-and-execution trade, and it carries real microcap risk.
Levels that matter:
- ~$4.48 — the 52-week high. A decisive breakout on volume opens fresh upside; rejection there is a natural spot for the run to pause.
- ~$3.58 (50-day) — the near-term support that's held the uptrend. Losing it is the first sign momentum is cooling.
- ~$2.43 (200-day) — deeper support and the line that defines whether the recovery trend is still intact.
- $1.10 — the 52-week low, a reminder of how far and fast this name can move in reverse.
How I'd treat it: size it as the speculative microcap it is — small, with a defined stop. The constructive entries are a breakout over $4.48 on volume, or a hold of the 50-day into the Q3 print with the beat-and-raise cadence continuing. A break of the 50-day, or any sign the awards aren't converting to margin, is the tell to step aside.
Horizon: a multi-quarter turnaround gated by new-program ramps and balance-sheet repair. Trade the levels; only build a position to the extent each quarter confirms the wins are becoming profitable revenue and the leverage is coming down.
Bottom Line
NNBR is a legitimately interesting small-cap turnaround — a left-for-dead precision-components maker that's beating, raising, and pointing itself at data-center cooling, the grid, defense, and medical, with a management team clearly executing and a balance sheet finally getting attention. That's a real re-rating story, and it's a genuinely different, several-layers-down way to play the AI and reshoring build. But it comes with the full microcap risk profile: sub-$4, leveraged, thin, already up ~3.5x, with the fast-growing pieces still a minority of a slow legacy base and much of the story riding on awards that have yet to convert. So the honest framing is a higher-risk momentum/turnaround name, not a stable compounder — own the operational inflection only as long as it keeps confirming, treat October 28 as the next proof point, and size for the volatility a sub-$4 industrial microcap will absolutely deliver. The execution is the bull's evidence; the balance sheet and the price already run are the bear's.
Price and technical data pulled live from Yahoo Finance at the September 29, 2026 session. Fundamentals from NN, Inc.'s Q2 2026 release (August 5, 2026) and its raised full-year guidance (September 22, 2026). Note the +19% headline sales growth is partly mix/new programs; the continuing base grew more modestly. Valuation figures are approximate. Levels are point-in-time and will move.